NCT02569814.
Methods | Randomised, open‐label, cross‐over assignment trial |
Participants | Healthy men, aged 19‐50 years |
Interventions | Group1 Fimasartan/amlodipine combination tablet and rosuvastatin individual tablets at 1st day as period I. And then, after wash out for 2 weeks, as period II, Group 1 participants take a fimasartan/amlodipine/rosuvastatin combination tablet at 15th day Group 2 A fimasartan/amlodipine/rosuvastatin combination tablet at 1st day as period I. And then, after wash out for 2 weeks, as period II, Group 2 participants take fimasartan/amlodipine combination tablet and rosuvastatin individual tablets at 15th day |
Outcomes |
Primary outcome ‐Cmax of fimasartan, amlodipine and rosuvastatin Secondary outcome ‐AUCt (Area Under the Curve) of fimasartan, amlodipine and rosuvastatin |
Notes |